scholarly journals Head and neck cancer surgery during the coronavirus pandemic: a single-institution experience

2021 ◽  
pp. 1-5
Author(s):  
J-P Jeannon ◽  
R Simo ◽  
R Oakley ◽  
W Townley ◽  
G Orfaniotis ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Cancer Patients ◽  
Neck Cancer ◽  
Elective Surgery ◽  
Care Pathway ◽  
Free Tissue Transfer ◽  
Complete Recovery ◽  
Cancer Surgery ◽  
Free Flap Surgery

Abstract Objective The coronavirus disease 2019 pandemic resulted in the cessation of elective surgery. The continued provision of complex head and neck cancer surgery was extremely variable, with some UK centres not performing any cancer surgery. During the pandemic, Guy's and St Thomas’ NHS Foundation Trust received high numbers of coronavirus disease 2019 admissions. This paper presents our experience of elective complex major head and neck cancer surgery throughout the pandemic. Methods A head and neck cancer surgery hub was set up that provided a co-ordinated managed care pathway for cancer patients during the pandemic; the Guy's Cancer Centre provided a separate, self-enclosed coronavirus-free environment within the hospital campus. Results Sixty-nine head and neck cancer patients were operated on in two months, and 13 patients had a microvascular free tissue transfer. Nosocomial infection with coronavirus disease 2019 was detected in two cases (3 per cent), neither required critical care unit admission. Both patients made a complete recovery and were discharged home. There were no deaths. Conclusion Performing major head and neck surgery, including free flap surgery, is possible during the pandemic; however, significant changes to conventional practice are required to achieve desirable patient outcomes.

scholarly journals The Roles of Albumin Levels in Head and Neck Cancer Patients with Liver Cirrhosis Undergoing Tumor Ablation and Microsurgical Free Tissue Transfer

PLoS ONE ◽  
2012 ◽  
Vol 7 (12) ◽  
pp. e52678 ◽  
Author(s):  
Huang-Kai Kao ◽  
Wei F. Chen ◽  
Chih-Hao Chen ◽  
Victor Bong-Hang Shyu ◽  
Ming-Huei Cheng ◽  
...  
Keyword(s):  
Liver Cirrhosis ◽  
Head And Neck Cancer ◽  
Head And Neck ◽  
Cancer Patients ◽  
Neck Cancer ◽  
Free Tissue Transfer ◽  
Tumor Ablation ◽  
Tissue Transfer

scholarly journals 7. Management of the Head and Neck Cancers Free Tissue Transfer in Head and Neck Cancer Surgery (I)

2010 ◽  
Vol 6 (2) ◽  
pp. 61-63
Author(s):  
Kazuhiko Yokoshima ◽  
Munenaga Nakamizo ◽  
Shunta Inai ◽  
Atsuko Sakanushi ◽  
Toshiaki Yagi
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Free Tissue Transfer ◽  
Cancer Surgery ◽  
Head And Neck Cancers ◽  
Tissue Transfer

scholarly journals End-of-life care pathway of head and neck cancer patients: single-institution experience

2017 ◽  
Vol 275 (2) ◽  
pp. 545-551 ◽  
Author(s):  
T. Heinonen ◽  
V. Loimu ◽  
K. Saarilahti ◽  
T. Saarto ◽  
A. Mäkitie
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
End Of Life ◽  
Cancer Patients ◽  
Neck Cancer ◽  
End Of Life Care ◽  
Care Pathway ◽  
Life Care ◽  
Single Institution

scholarly journals UK Head and neck cancer surgical capacity during the second wave of the COVID-19 pandemic -- have we learned the lessons? COVIDSurg collaborative

2021 ◽  
Author(s):  
richard shaw ◽  
Paul Nankivell ◽  
Stuart Winter ◽  
Andrew Schache ◽  
Michael Ho
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Cancer Patients ◽  
Neck Cancer ◽  
Cancer Surgery ◽  
Surgical Capacity ◽  
Specialist Service ◽  
Tertiary Hospitals ◽  
The Uk ◽  
Second Wave

Objectives - The aim of this study was to evaluate the differences in surgical capacity for head and neck cancer in the UK between the first wave (March-June 2020) and the current wave (Jan-Feb 2021) of the COVID-19 pandemic. Design – REDcap online based survey of hospital capacity. Setting - UK secondary and tertiary hospitals providing head and neck cancer surgery. Participants – One representative per hospital was asked to report the capacity for head and neck cancer surgery in that institution. Main outcome measures – The principal measures of interests were new patient referrals, capacity in outpatients, theatres and critical care; therapeutic compromises constituting delay to surgery, de-escalated surgery and therapeutic migration to non-surgical primary modality. Results – Data was returned from approximately 95% of UK hospitals with a head and neck cancer surgery specialist service. 50% of UK head and neck cancer patients requiring surgery have significantly compromised treatments during the second wave: 28% delayed, 10% have received radiotherapy based treatment instead of surgery and 12% have received de-escalated surgery. Surgical capacity has been more severely constrained in the second wave (58% of pre-pandemic level) compared with the first wave (62%) despite the time to prepare. Conclusions - Some hospitals are overwhelmed by COVID-19 and unable to offer essential cancer surgery, but all have neighbouring hospitals in their region retaining good (or even normal) capacity. It is noteworthy that very few patients have been appropriately re-directed away from the hospitals most constrained by their burden of COVID-19. The paucity of an effective central or regional strategic response to this evident mismatch between demand and surgical capacity is to the detriment of our head and neck cancer patients.

Sign in / Sign up

Export Citation Format

Share Document